Back
Corvus Pharmaceuticals Vs. Triumph Financial Industry Stock Comparison
Buy
56
CRVS
Corvus Pharmaceuticals
Last Price:
1.81
Seasonality Move:
20.23%
Buy
62
TFIN
Triumph Financial
Last Price:
81.66
Seasonality Move:
13.92%
Buy
56
Corvus Pharmaceuticals (CRVS)
is a Buy
Is Corvus Pharmaceuticals a Buy, Sell or Hold?
- The current Corvus Pharmaceuticals [CRVS] share price is $1.82. The Score for CRVS is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- CRVS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Triumph Financial (TFIN)
is a Buy
Is Triumph Financial a Buy, Sell or Hold?
- The current Triumph Financial [TFIN] share price is $81.69. The Score for TFIN is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- TFIN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CRVS Stock Price Chart
What is Corvus Pharmaceuticals's stock price today?
-
The Corvus Pharmaceuticals share price today is $1.82
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRVS is experiencing slight selling pressure.
TFIN Stock Price Chart
What is Triumph Financial's stock price today?
-
The Triumph Financial share price today is $81.69
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TFIN is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRVS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 42.11 | Sell |
Chaikin Money Flow: | -79127 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.87 - 2.15) | Sell |
Bollinger Bands (100): | (1.68 - 2.22) | Sell |
TFIN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.2 | Buy |
Relative Strength Index (14 RSI): | 64.95 | Buy |
Chaikin Money Flow: | 537139 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (72.77 - 77.51) | Buy |
Bollinger Bands (100): | (72.6 - 77.7) | Buy |
CRVS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.84 | Sell |
20-day SMA: | 2 | Sell |
50-day SMA: | 1.93 | Sell |
200-day SMA: | 1.78 | Buy |
8-day EMA: | 1.86 | Sell |
20-day EMA: | 1.94 | Sell |
50-day EMA: | 1.95 | Sell |
200-day EMA: | 1.87 | Sell |
TFIN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 77.67 | Buy |
20-day SMA: | 75.51 | Buy |
50-day SMA: | 74 | Buy |
200-day SMA: | 72.08 | Buy |
8-day EMA: | 77.73 | Buy |
20-day EMA: | 76.19 | Buy |
50-day EMA: | 75.17 | Buy |
200-day EMA: | 72.16 | Buy |
Corvus Pharmaceuticals Earnings Growth & CRVS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.07 per share, and a decrease next year of $0.07 per share.
Triumph Financial Earnings Growth & TFIN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.14 per share, a decrease this year of $0.53 per share, and an increase next year of $1.20 per share.
Corvus Pharmaceuticals Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Triumph Financial Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |